Expect Caplyta and Secuado to Continue on Admission
Patients may come in on new atypical antipsychotics...Caplyta (kah-PLY-tah, lumateperone) or Secuado (seh-KWAH-doh, asenapine).
Caplyta is a 42 mg oral capsule that's taken once daily.
Expect it to be saved for patients with schizophrenia who don't respond to or can't tolerate lower-cost atypicals, such as olanzapine or risperidone.
Get unlimited access through an Enterprise license
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals